Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Fetal Fibronectin (fFN) in Predicting Preterm Delivery Due to Abruptio Placenta in Patients With Minor Maternal Trauma.

NCT01279369 is registered in ClinicalTrials.gov with Winthrop University Hospital as lead sponsor.

NCT NCT01279369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01279369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Fetal Fibronectin (fFN) in Predicting Preterm Delivery Due to Abruptio Placenta in Patients With Minor Maternal Trauma.
Lead sponsor
Winthrop University Hospital
Phase
Observational
Overall status
Terminated
Start date
October 31, 2009
Completion date
October 31, 2012
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abruptio placentae, pregnancy related, trauma